TOMSK, RUSSIA / RankWire.AI / – Russian scientists have investigated a bioactive coating aimed at improving the interaction between titanium orthopedic implants and bone tissue. The innovative material incorporates calcium phosphate sourced from hydroxyapatite and includes nitrogen compounds linked to nitric oxide synthesis. Laboratory experiments demonstrated that human mesenchymal stem cells exhibited significantly increased survival rates on surfaces coated with this material compared to uncoated titanium. The research team analyzed the coating’s structure, chemical makeup, mechanical strength, and biological response. Their peer-reviewed results appeared in Applied Surface Science in 2026.
At Tomsk Polytechnic University, researchers created the experimental coatings via reactive magnetron sputtering of a hydroxyapatite target within a vacuum chamber. They adjusted the nitrogen-to-argon ratio during deposition to observe how each mixture influenced the resulting surface. The study tested five different conditions, from pure nitrogen to pure argon. They then measured parameters including coating thickness, surface morphology, hardness, wettability, and chemical composition. Additionally, laboratory tests assessed how living human cells responded to the modified titanium surfaces.
Results indicated that the argon content impacted multiple physical properties of the coatings. Surfaces produced in pure argon proved denser and harder than those created with pure nitrogen. Coating thickness also increased proportionally with the rise in argon concentration. Chemical analysis revealed nitrogen-carbon and nitrogen-oxygen bonds present on the modified surfaces. The team then compared the behavior of human mesenchymal stem cells grown on coated titanium against those on uncoated titanium. The biological testing evaluated cell viability as well as markers associated with bone cell differentiation.
Enhanced Cell Survival Observed with Coated Implants
According to the research, cell experiments showed that survival rates were significantly higher on coated surfaces than on uncoated titanium. After seven days, coatings with elevated nitrogen levels also suppressed the activity of certain genes involved in early bone-cell development. Despite this, the cells maintained their potential for bone formation. These assessments were conducted under controlled laboratory conditions with human mesenchymal stem cells, and the study did not involve testing the coating in patients or evaluating clinical outcomes of implanted devices.
The biomedical evaluation was carried out by researchers from Immanuel Kant Baltic Federal University and Siberian State Medical University, with additional participation from scientists at Saint Petersburg State University. The project received backing from Russia’s national science program. The investigators aimed to identify gas mixtures capable of producing beneficial combinations of physical, chemical, and biological properties in the coatings. Hydroxyapatite has already been used in implant coatings due to its calcium phosphate composition, which closely resembles the mineral found in human bone.
Research Still in the Laboratory Phase
The team has planned further testing beyond the initial seven-day cell experiments. Future studies will involve monitoring stem cells over periods ranging from 10 to 28 days, alongside investigations into how rapidly the coatings dissolve and how nitric oxide is released into surrounding tissue in living organisms. These additional tests were not included in the published laboratory results. The current research focuses on coated titanium substrates, their physical and chemical properties, and in vitro cellular responses, rather than clinical applications involving orthopedic patients.
The findings offer comprehensive laboratory data on how varying ratios of nitrogen and argon influence calcium phosphate coatings on titanium surfaces. The researchers documented differences in coating thickness, density, hardness, chemical bonding, and cellular response across the different gas mixtures. The study also confirmed that coated samples supported higher stem-cell survival than uncoated titanium under laboratory conditions. However, as a preclinical investigation, the research does not establish safety or effectiveness in humans. Additional biological testing will be necessary to evaluate properties not covered in this initial study.